Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer

Gynecologic Oncology

Volumn 111, Issue 3, 2008, Pages 546-548

  Buttin, Barbara M ^a   Moore, Michael J ^a  

^a Section Hematology/Oncology   (United States)

Author keywords

Drug induced interstitial lung disease; Interstitial pneumonitis; Ovarian cancer; Thalidomide

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; PACLITAXEL; THALIDOMIDE; TOPOTECAN;

ADULT; ARTICLE; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MULTIPLE CYCLE TREATMENT; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; RECURRENT CANCER; TRANSBRONCHIAL BIOPSY;

ANGIOGENESIS INHIBITORS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; THALIDOMIDE;

EID: 56749177513     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.005     Document Type: Article

References (10)

1. D'Amato R.J., Loughnan M.S., Flynn E., and Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci 91 (1994) 4082-4085
2. Rajkumar S.V., Hayman S., Gertz M.A., Dispenzieri A., Lacy M.Q., Greipp P.R., et al. Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol 20 (2002) 4319-4323
3. Onozawa M., Hashino S., Sogabe S., Haneda M., Morimoto H., Izumiyama K., et al. Thalidomide-induced interstitial pneumonitis. J Clin Oncol 23 (2005) 2425-2426
4. Costabel U., Uzaslan E., and Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 25 (2004) 25-35
5. Chan J.K., Manuel M.R., Ciaravino G., Cheung M.K., Husain A., and Teng N.N.H. Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. Gynecol Oncol 103 (2006) 919-923
6. Gordinier M.E., Dizon D.S., Weitzen S., Disilvestro P.A., Moore R.G., and Granai C.O. Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer. J Palliative Med 10 (2007) 61-66
7. Gordinier M.E., and Dizon D.S. Dyspnea during thalidomide treatment for advanced ovarian cancer. Ann Pharmacother 39 (2005) 962-965
8. Carrion Valero F., and Bertomeu Gonzales V. Lung toxicity due to thalidomide [Spanish]. Arch Bronconeumol 38 (2002) 492-494
9. Behrens R.J., Gulley J.L., and Dahut W.L. Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomide. Am J Ther. 10 (2003) 228-232
10. Downs Jr L, Judson P, Argenta P, Ghebre R, Geller MA, Bliss RL, et al. A prospective randomized trial of thalidomide with topotecan compared to topotecan alone in women with recurrent epithelial ovarian, primary peritoneal or fallopian tube carcinoma. Cancer in press [Electronic publication ahead of print].